Regulatory T cells are defined by FOXP3 and suppress through at least four distinct mechanisms; their loss removes restraint on self-reactive cells without reducing effector capacity, so the outcome is autoimmunity, not immunodeficiency.
Four suppression routes
- IL-2 consumption: CD25 on Tregs strips IL-2 from the local environment, starving conventional T cells of their main growth signal.
- Inhibitory cytokines: IL-10 and TGF-beta dampen dendritic cell maturation and effector T-cell activation.
- Contact-dependent inhibition: CTLA-4 removes CD80 and CD86 from dendritic cells, cutting off costimulation to conventional T cells.
- Metabolic and cytolytic suppression: adenosine generation and granzyme/perforin-mediated killing of target cells.
Because Tregs restrain rather than execute, their failure does not reduce the ability to fight infection. Effector T cells and B cells remain fully capable; what is lost is the brake. The clinical signature is therefore tissue-directed inflammation and autoantibody production, not opportunistic infection. This is the mechanistic distinction between regulatory failure and the effector failures covered in earlier chapters.